B-MS transfers US rights for Erbitux to Lilly after 14 years
Bristol-Myers Squibb will transfer the US rights to Erbitux to Eli Lilly, which makes the monoclonal antibody through its subsidiary ImClone.
Archives for April 20, 2015
US arthritis patients will still face high costs when biosimilars are available says researcher
US rheumatoid arthritis (RA) sufferers will still face high drug prices after biosimilar are available unless insurers reclassify such meds according to the author of research on biologic DMARD costs.
Gene therapy tech could be 'game-changer' for CNS biologics, says Medgenics
Medgenics has expanded a partnership with Harvard University to use its Transduced Autologous Regenerative Gene Therapy (TARGT) platform for potential applications involving the central nervous system.